Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system (Q41827081)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 1999
edit
Language Label Description Also known as
English
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system
scientific article published on September 1999

    Statements

    Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system (English)
    1 reference
    Culig Z
    1 reference
    Hoffmann J
    1 reference
    Erdel M
    1 reference
    Eder IE
    1 reference
    Hobisch A
    1 reference
    Hittmair A
    1 reference
    Bartsch G
    1 reference
    Utermann G
    1 reference
    Schneider MR
    1 reference
    Parczyk K
    1 reference
    Klocker H
    1 reference
    1 September 1999
    1 reference
    81
    1 reference
    242-251
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit